The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy.
Marloes E van MuijenTamara W van HalHans M M GroenewoudJuul M P A van den ReekElke M G J de JongPublished in: Psoriasis (Auckland, N.Z.) (2020)
Clinical risk factors might be inaccurate to predict PsA onset in patients with moderate-to-severe psoriasis on biologics. Even with low disease activity, psoriasis patients on biologics are still prone to develop PsA.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- disease activity
- prostate cancer
- ejection fraction
- risk factors
- newly diagnosed
- systemic lupus erythematosus
- peritoneal dialysis
- primary care
- prognostic factors
- stem cells
- early onset
- patient reported outcomes
- rheumatoid arthritis patients
- mesenchymal stem cells
- smoking cessation
- drug induced